Mads Krogsgaard Thomsen, CEO of Novo Nordisk Foundation, discusses European competitiveness.

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland ...

(Reuters) - European shares were subdued on Tuesday, as rising financials and healthcare shares countered broader losses ...

By Nikhil Sharma and Pranav Kashyap (Reuters) -European shares rose on Tuesday, buoyed by gains in the healthcare and luxury ...

Mexico and China — as he has increasingly spoken of the U.S. taking Greenland off Denmark’s hands. Danish multinational pharmaceutical giant Novo Nordisk is the sole owner of semaglutide ...

Denmark is the leading supplier of hearing aids to the U.S., per The Times, and is home to Novo Nordisk, the maker of ... wants 25% tariffs on imports from Mexico and Canada and an additional ...

Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

European shares held steady with slight gains in financials and healthcare despite global uncertainties over U.S. President Donald Trump's proposed tariffs. The market's cautious optimism was ...

For example, he proposed 25% tariffs on imports from Canada and Mexico, the two biggest trading ... What do Trump's tariffs have to do with Eli Lilly? Novo Nordisk (NYSE: NVO) is based in Denmark ...